会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Tissue oxygenation monitoring in heart failure
    • 心力衰竭组织氧合监测
    • US08571620B2
    • 2013-10-29
    • US12797816
    • 2010-06-10
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • A61B5/00
    • A61N1/36557
    • A medical device system and associated method are used for monitoring a heart failure patient. A medical device for monitoring delivery of a therapy includes a sensor sensing an optical sensor signal corresponding to light attenuation by a volume of body tissue of a patient, a therapy delivery module to deliver a therapy, and a processor configured to compute a first tissue oxygenation measurement from the optical sensor signal prior to initiating delivery of the therapy, compute a second tissue oxygenation measurement from the optical sensor signal subsequent to initiating delivery of the therapy, compare the first and the second tissue oxygenation measurements, and determine whether the delivered therapy was successful in response to the first tissue oxygenation measurement and the second tissue oxygenation measurement.
    • 医疗器械系统和相关方法用于监测心力衰竭患者。 用于监测治疗递送的医疗装置包括传感器,其感测对应于患者的身体组织的体积的光衰减的光学传感器信号,用于递送治疗的治疗递送模块和被配置为计算第一组织氧合的处理器 在开始递送治疗之前从光学传感器信号进行的测量,在开始递送治疗之后从光学传感器信号计算第二组织氧合测量,比较第一和第二组织氧合测量,并确定递送的治疗是否为 成功地响应于第一次组织氧合测量和第二次组织氧合测量。
    • 4. 发明申请
    • Tissue Oxygenation Monitoring in Heart Failure
    • 心力衰竭组织氧合监测
    • US20100317942A1
    • 2010-12-16
    • US12797816
    • 2010-06-10
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • Can CinbisJames K. CarneyJonathan L. KuhnDavid A. Anderson
    • A61B5/00
    • A61N1/36557
    • A medical device system and associated method are used for monitoring a heart failure patient. A medical device for monitoring delivery of a therapy includes a sensor sensing an optical sensor signal corresponding to light attenuation by a volume of body tissue of a patient, a therapy delivery module to deliver a therapy, and a processor configured to compute a first tissue oxygenation measurement from the optical sensor signal prior to initiating delivery of the therapy, compute a second tissue oxygenation measurement from the optical sensor signal subsequent to initiating delivery of the therapy, compare the first and the second tissue oxygenation measurements, and determine whether the delivered therapy was successful in response to the first tissue oxygenation measurement and the second tissue oxygenation measurement.
    • 医疗器械系统和相关方法用于监测心力衰竭患者。 用于监测治疗递送的医疗装置包括传感器,其感测对应于患者的身体组织的体积的光衰减的光学传感器信号,用于递送治疗的治疗递送模块和被配置为计算第一组织氧合的处理器 在开始递送治疗之前从光学传感器信号进行的测量,在开始递送治疗之后从光学传感器信号计算第二组织氧合测量,比较第一和第二组织氧合测量,并确定递送的治疗是否为 成功地响应于第一次组织氧合测量和第二次组织氧合测量。
    • 7. 发明申请
    • Shock Reduction Using Absolute Calibrated Tissue Oxygen Saturation and Total Hemoglobin Volume Fraction
    • 使用绝对校准的组织氧饱和度和总血红蛋白体积分数进行减震
    • US20100318149A1
    • 2010-12-16
    • US12797793
    • 2010-06-10
    • Jonathan L. KuhnCan CinbisDavid A. AndersonJames K. Carney
    • Jonathan L. KuhnCan CinbisDavid A. AndersonJames K. Carney
    • A61N1/365
    • A61N1/3622A61B5/02028A61B5/0215A61B5/042A61B5/1116A61B5/14542A61B5/1459A61N1/36557A61N1/3956
    • An implantable medical device that includes an optical sensor for providing a signal corresponding to light attenuation by a volume of blood perfused tissue, a control module coupled to the optical sensor controlling the light emitted by the optical sensor, a monitoring module receiving an optical sensor output signal and measuring light attenuation, a tissue electrode for stimulating the volume of blood perfused tissue, a pulse generator coupled to the tissue electrode for delivering electrical stimulation to the volume of blood-perfused tissue, and a processor coupled to the cardiac electrode and the monitoring module and configured to detect an arrhythmia in response to the depolarization signals, compute a tissue oxygenation measurement and control the pulse generator to deliver electrical stimulation to the volume of blood-perfused tissue in response to detecting the arrhythmia, and detect a hemodynamic status of the arrhythmia in response to at least one of a detected rate of tissue oxygenation decline and a detected rate of tissue oxygenation recovery.
    • 一种可植入医疗装置,其包括:光学传感器,用于通过一定量的血液灌注组织提供对应于光衰减的信号;耦合到所述光学传感器的控制模块,所述控制模块控制由所述光学传感器发射的光;监测模块,其接收光学传感器输出 信号和测量光衰减的组织电极,用于刺激血液灌注组织的体积的组织电极,耦合到组织电极的脉冲发生器,用于向血液灌注组织的体积输送电刺激;以及处理器,其耦合到心脏电极和监测 模块并且被配置为响应于去极化信号检测心律失常,计算组织氧合测量并控制脉冲发生器以响应于检测到心律失常而向血液灌注组织的体积递送电刺激,并且检测血液动力学状态 响应于检测到的tis的速率中的至少一种的心律失常 检测氧合反应的下降和组织氧合恢复率。
    • 8. 发明授权
    • Shock reduction using absolute calibrated tissue oxygen saturation and total hemoglobin volume fraction
    • 使用绝对校准的组织氧饱和度和总血红蛋白体积分数进行减震
    • US08391979B2
    • 2013-03-05
    • US12797793
    • 2010-06-10
    • Jonathan L. KuhnCan CinbisDavid A. AndersonJames K. Carney
    • Jonathan L. KuhnCan CinbisDavid A. AndersonJames K. Carney
    • A61N1/00
    • A61N1/3622A61B5/02028A61B5/0215A61B5/042A61B5/1116A61B5/14542A61B5/1459A61N1/36557A61N1/3956
    • An implantable medical device that includes an optical sensor for providing a signal corresponding to light attenuation by a volume of blood perfused tissue, a control module coupled to the optical sensor controlling the light emitted by the optical sensor, a monitoring module receiving an optical sensor output signal and measuring light attenuation, a tissue electrode for stimulating the volume of blood perfused tissue, a pulse generator coupled to the tissue electrode for delivering electrical stimulation to the volume of blood-perfused tissue, and a processor coupled to the cardiac electrode and the monitoring module and configured to detect an arrhythmia in response to the depolarization signals, compute a tissue oxygenation measurement and control the pulse generator to deliver electrical stimulation to the volume of blood-perfused tissue in response to detecting the arrhythmia, and detect a hemodynamic status of the arrhythmia in response to at least one of a detected rate of tissue oxygenation decline and a detected rate of tissue oxygenation recovery.
    • 一种可植入医疗装置,其包括:光学传感器,用于通过一定量的血液灌注组织提供对应于光衰减的信号;耦合到所述光学传感器的控制模块,所述控制模块控制由所述光学传感器发射的光;监测模块,其接收光学传感器输出 信号和测量光衰减的组织电极,用于刺激血液灌注组织的体积的组织电极,耦合到组织电极的脉冲发生器,用于向血液灌注组织的体积输送电刺激;以及处理器,其耦合到心脏电极和监测 模块并且被配置为响应于去极化信号检测心律失常,计算组织氧合测量并控制脉冲发生器以响应于检测到心律失常而向血液灌注组织的体积递送电刺激,并且检测血液动力学状态 响应于检测到的tis的速率中的至少一种的心律失常 检测氧合反应的下降和组织氧合恢复率。